Forty Seven, Inc. Prices Underwritten Public Offering of 9,375,000 Shares of Common Stock

MENLO PARK, Calif., July 17, 2019 (GLOBE NEWSWIRE) -- Forty Seven, Inc. (Nasdaq: FTSV), a clinical stage immuno-oncology company, today announced the pricing of its previously announced underwritten public offering of 9,375,000 shares of its common stock at a price to the public of $8.00 per share.  Gross proceeds to Forty Seven from the offering are expected to be $75,000,000, before deducting underwriting discounts and commissions and estimated offering expenses.  All of the shares of common stock are being offered by Forty Seven. In addition, Forty Seven has granted the underwriters a 30-day option to purchase up to 1,406,250 of additional shares of common stock at the public offering price, less underwriting discounts and commissions.  The offering is expected to close on July 22, 2019, subject to customary closing conditions.

Click to view original post